| Sources | Names Used |
|---|---|
| CTRPv2 | Compound 1541A |
| PharmacoGx | Compound 1541A |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KLHL15 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | AGO3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | OR2AJ1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | HRH3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | LATS1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | ZNF517 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | TNRC6C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | AEN | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | RP11-500M8.7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
